• Home
  • About
    • International Neuropsychiatric Association
    • Mission Statement
    • Awards
    • Committees
    • INA Board Members
    • History
    • Global Neuropsychiatry Group
    • GNG/INA International Representatives
  • Membership
  • Member Login
  • News and Events
  • Contact
Home
News

News

FDA Approves New Drug to Treat Parkinson’s-Related Psychosis

Pimavanserin (Nuplazid), a drug used to treat symptoms of psychosis related to Parkinson’s disease, has just…
10 October, 2019

Neurology Devices Market Size to Reach $10.8 Billion by 2022: Grand View Research, Inc.

Global neurology devices market is expected to reach USD 10.8 billion by 2022, according to a…
10 October, 2019

Immuno-psychiatry: When your body makes its own ‘angel dust’

A new study in Biological Psychiatry reports structural brain damage from an autoimmune encephalitis that impairs…
10 October, 2019

Conventional radiation therapy may not protect healthy brain cells

A new study shows that repeated radiation therapy used to target tumors in the brain may…
10 October, 2019

Complain All You Want, But Your Busy Schedule May Help Your Brain

Single mothers, untenured professors, young reporters and on-call doctors might have a thin silver lining for…
10 October, 2019

Researchers shed light on pathway from virus to brain disease

Why people on immunosuppressant drugs for autoimmune conditions have a higher incidence of an often-fatal brain…
10 October, 2019

Contact the INA

© Copyright International Neuropsychiatric Association | Your right to privacy
This website uses cookies to ensure you get the best experience on our website.